Global X Management Company’s Amedisys AMED Stock Holding History

Global X Management Company’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$49K	Sell	574 -11	-2%	-$808	﹤0.01%	1092
2018 Q1	$35K	Buy	585 +147	+34%	+$8.37K	﹤0.01%	1064
2017 Q4	$23K	Buy	438 +99	+29%	+$5.22K	﹤0.01%	1017
2017 Q3	$19K	Buy	339 +48	+16%	+$2.54K	﹤0.01%	1069
2017 Q2	$18K	Buy	291 +193	+197%	+$11.2K	﹤0.01%	1165
2017 Q1	$5K	Buy	98 +6	+7%	+$286	﹤0.01%	1175
2016 Q4	$4K	Hold	92	–	–	﹤0.01%	1068
2016 Q3	$4K	Hold	92	–	–	﹤0.01%	1076
2016 Q2	$5K	Buy	+92	New	+$4.64K	﹤0.01%	924

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Global X Management Company's AMED Position: Q2 2018 in Review

Global X Management Company reduced its Amedisys (AMED) stake by 1.9% in Q2 2018, selling an estimated $808 and leaving 574 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Global X Management Company first reported a position in AMED in Q2 2016 and has held it in 9 quarters since. 216 funds tracked by Wall St. Rank hold AMED as of Q2 2018.

Global X Management Company held 574 shares of Amedisys worth $49K as of Q2 2018.
Global X Management Company sold 11 Amedisys shares in Q2 2018, an estimated $808.
Amedisys made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1092 holding.
Global X Management Company first reported a position in Amedisys in Q2 2016 and has held it in 9 quarters since.
216 funds tracked by Wall St. Rank held Amedisys as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.